emilpharma 
Dealstreet

ELP acts on Somerset Indus Capital Partners' investment in Emil Pharmaceutical

The deal amount remains undisclosed.

Bar & Bench

Somerset Indus Capital Partners has made an investment in Emil Pharmaceutical Industries Pvt Ltd, a pharmaceutical contract development and manufacturing organization. This marks the fund’s fifth overall and second pharmaceutical investment from its Fund II.

Economic Laws Practice advised Somerset Indus Capital Partners in this deal.

The transaction team consisted of Vinay Butani (Partner), Taskeen Hamid (Counsel) and Vinit Shah (Senior Associate).

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Delhi High Court restrains sale of merchandise infringing NTR Junior's personality rights

Chhattisgarh High Court grants bail to ex-CM's son Chaitanya Baghel in liquor scam

Kickstart your litigation career with Lis Peritus Certificate Course with real courtroom simulation

Khaitan, TT&A act on L Catterton's investment in Haldiram

CAM advises Zenrock Chemicals and EAAA India on acquiring promoter stake in Indo Borax & Chemicals

SCROLL FOR NEXT